Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function

Polish Journal of Pharmacology

Volumn 54, Issue 4, 2002, Pages 343-349

  Budziszewska, Bogusława ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressants; Depression; Glucocorticoid receptors; Hypothalamic pituitary adrenal axis

Indexed keywords

AMINOGLUTETHIMIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; CITALOPRAM; CORTICOSTEROID ANTAGONIST; CORTICOTROPIN RECEPTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DESIPRAMINE; DEXAMETHASONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; IMIPRAMINE; KETOCONAZOLE; LITHIUM; MAPROTILINE; METYRAPONE; MIANSERIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; OXAPROTILINE; REBOXETINE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZIMELDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; CUSHING SYNDROME; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; INCIDENCE; MONOAMINERGIC SYSTEM; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; RAT; REVIEW; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID;

EID: 0036385140     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. 1, agonists in the rat. Neuroendocrinology, 1989, 50, 241-247.
2. Brady L. S., Whitfield H. J., Fox R. J., Gold P. W., Herkenham M.: Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J. Clin. Invest., 1991, 87, 831-837.
3. Budziszewska B., Jaworska-Feil L., Kajta M., Lasoń W: Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism. Brit. J. Pharmacol., 2000, 130, 1385-1393.
4. Budziszewska B., Siwanowicz J., Przegaliński E.: The effect of chronic treatment with antidepressant drugs on the corticosteroid receptor levels in the rat hippocampus. Pol. J. Pharmacol., 1994, 46, 147-152.
5. Coppen A.J., Doogan D.P.: Serotonin and its place in the etiopathogenesis of depression. J. Clin. Psychiat., 1988, 49, Suppl. 8, 4-11.
6. De Bellis M.D., Gold P.W., Geracioti T.D.Jr., Listwak S.J., Kling M.A.: Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Amer. J. Psychiat., 1993, 150, 656-657.
7. De Kloet E.R.: Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol., 1991, 12, 95-164.
8. Elliott E., Sapolsky R.: Glucocorticoids, neurotoxicity and calcium regulation. In: Neurosteroids and Brain Function. Eds. Costa E., Paul S.M., Fidia Research Foundation, Thieme Medical Publishers, Inc., New York, 1991, 47-54.
9. Fadda P., Pani L., Porcella A., Fratta W.: Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain. Neurosci. Lett., 1995, 192, 121-123.
10. Heuser I. J. E., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., Holsboer F.: Pituitary-adrenal system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Amer. J. Psychiat., 1996, 153, 93-99.
11. Holsboer F.: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 2000, 23, 477-501.
12. Holsboer F., Barden N.: Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev., 1996, 17, 187-205.
13. Holsboer F., Gerken A., Stalla G.K., Muller O.A.: ACTH, cortisol and corticosterone output after ovine corticotrophin-releasing factor challenge during depression and after recovery. Biol. Psychiat., 1985, 20, 276-286.
14. Holsboer F., Lauer C. J., Schreiber W., Krieg J.-C.: Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology, 1995, 62, 340-347.
15. Itoi K., Horiba N., Tozawa F., Sakai Y., Sakai K., Abe K., Demura H., Suda T.: Major role of 3'5'-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivo. Endocrinology, 1996, 137, 2389-2396.
16. Jackson I.M., Luo L.G.: Antidepressants inhibit the glucocorticoid stimulation of thyrotropin releasing hormone expression in cultured hypothalamic neurons. J. Invest. Med., 1998, 46, 470-474.
17. Jeffcoate W.J., Silverstone J.T., Edwards C.R.W, Besser G.M.: Psychiatric manifestations of Cushing's Syndrome: response to lowering of plasma cortisol. Quart. J. Med., 1979, 191, 465-472.
18. Kuroda Y., Mikuni M., Ogawa T., Takahashi K.: Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology, 1992, 108, 27-32.
19. Legradi G., Holzer D., Kapcala L.P., Lechan R.M.: Glucocorticoids inhibit stress-induced phosphorylation of CREB in corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology, 1997, 66, 86-97.
20. Ling M.H., Perry P.J., Tsuang M.T.: Side effects of corticosteroid therapy. Psychiatric aspects. Arch. Gen. Psychiat., 1981, 38, 471-477.
21. Linkowski P., Mendlewicz J., LeClerc R., Brasseur M., Hubain P., Goldstein J., Copinschi G., Van Cauter E.: The 24-hour profile of ACTH and cortisol in major depressive illness. J. Clin. Endocrinol. Metab., 1985, 61, 429-438.
22. Lowy M.T., Gault L., Yamamoto B.K.: Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J. Neurochem., 1993, 61, 1957-1960.
23. Maccari S., Le Moal M., Angelucci L., Mormede P.: Influence of 6-OHDA lesion of central noradrenergic systems on corticosteroid receptors and neuroendocrine responses to stress. Brain Res., 1990, 533, 60-65.
24. Magarinos A.M., Verdugo J.M., McEwen B.S.: Chronic stress alters synaptic terminal structure in hippocampus. Proc. Nat. Acad. Sci. USA, 1997, 94, 14002-14008.
25. McEwen B.S.: Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem. Pharmacol., 1987, 36, 1755-1763.
26. Meijer O.C., de Kloet E.R.: Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur. J. Pharmacol., 1994, 266, 255-261.
27. Mitchell J.B., Rowe W., Boksa P., Meaney M.J.: Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures. J. Neurosci., 1990, 10, 1745-1752.
28. Montkowski A., Barden N., Wotjak C., Stec I., Ganster J., Meaney M., Engelmann M., Reul J. M. H. M., Landgraf R., Holsboer F.: Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol., 1995, 7, 841-845.
29. Murphy B.E.P.: Antiglucocorticoid therapies in major depression: a review. Psychoneuroendocrinology, 1997, 22, Suppl. 1, S125-SI32.
30. Nemeroff C. B., Widerlov E., Bisette G., Walleus H., Karlsson I., Eklund K., Kilts C. D., Loosen P. T., Vale W.: Elevated concentrations of CSF corticotropin releasing factor-like immunoreactivity in depressed patients. Science, 1984, 226, 1342-1344.
31. Nibuya M., Morinobu S., Duman R.S.: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci., 1995, 15, 7539-7547.
32. Pariante C.M., Miller A.H.: Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiat., 2001, 49, 391-404
33. Pariante C. M., Pearce B. D., Pisell T. L., Owens M. J., Miller A.H.: Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmacol., 1997, 52, 571-581.
34. Peiffer A., Veilleux S., Barden N.: Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology, 1991, 16, 505-515.
35. Pepin M.-C., Beaulieu S., Barden.: Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol. Brain Res., 1989, 6, 77-83.
36. Pepin M.-C., Govindan M. V, Barden N.: Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol., 1992, 41, 1016-1022.
37. Pepin M.-C., Pothier F., Barden N.: Impaired glucocorticoid receptor function in transgenic mice expressing antisense RNA. Nature, 1992, 355, 725-728.
38. Przegaliński E., Budziszewska B.: The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats. Neurosci. Lett., 1993, 161, 215-218.
39. Przegaliński E., Budziszewska B., Siwanowicz J., Jaworska L.: The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats. Neuropharmacology, 1993, 32, 1397-1400.
40. Raadsheer F.C., Hoogendijk W.J.G., Starn F.C., Tilders F.J.H., Swaab D.F.: Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology, 1994, 460, 436-444.
41. Ratka A., Sutanto W., Bloemers M., De Kloet E.R.: On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology, 1989, 50, 117-123.
42. Raven P.W., O'Dwyer A.-M., Taylor N.F., Checkley S.A.: The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles. Psychoneuroendocrinology, 1996, 21, 277-286.
43. Rossby S.P., Nalepa I., Huang M., Burt A., Perrin C., Schmidt D.E., Sulser F.: Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Res., 1995, 687, 79-82.
44. Rousse I., Beaulieu S., Rowe W., Meaney M. J., Barden N., Rochford J.: Spatial memory in transgenic mice with impaired glucocorticoid receptor function. NeuroReport, 1997, 8, 841-845.
45. Schwaninger M., Schofl C., Blume R., Rossig L., Knepel W.: Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol., 1995, 47, 1112-1118.
46. Seckl J. R., Fink G.: Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology, 1992, 55, 621-626.
47. Siegel R.A., Weidenfeld J., Chen M.: Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine. Mol. Cell. Endocrinol., 1983, 31, 253-259.
48. Twardowska K., Rybakowski J.: Limbic-hypothalamic-pituitary-adrenal axis in depression (Polish). Psychiatria Polska, 1996, 30, 741-756.
49. Watanabe Y., Gould E., Daniels D. C., Cameron H., McEwen B. S.: Tianeptine attenuates stress-induced morphological changes in the hippocampus. J. Pharmacol., 1992, 222, 157-162.
50. Young A.H., MacDonald L.M., St John H., Dick H., Goodwin G.M.: The effects of corticosterone on 5-HT receptor function in rodents. Neuropharmacology, 1992, 31, 433-438.